Fletikumab
Modify Date: 2024-09-17 15:27:57
Fletikumab structure
|
Common Name | Fletikumab | ||
|---|---|---|---|---|
| CAS Number | 1357158-22-5 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of FletikumabFletikumab (NNC0109-0012) is a monoclonal antibody targeting to IL-20. Fletikumab can be used for inflammation research, such as rheumatoid arthritis[1]. |
| Name | Fletikumab |
|---|
| Description | Fletikumab (NNC0109-0012) is a monoclonal antibody targeting to IL-20. Fletikumab can be used for inflammation research, such as rheumatoid arthritis[1]. |
|---|---|
| Related Catalog | |
| Target |
IL-20[1] |
| In Vitro | Fletikumab blocks IL-20 binding IL-20 receptor, acts potential function of inflammation inhibition[1]. IL-20 is a member of IL-10 family, which includes IL-10, IL-19, IL-22, IL-24, IL-26, IL-28, and IL-29. IL-20 acts on renal cells and contributes to inflammation, fibrosis, and apoptosis through its receptors IL-20R1, IL-20R2, and IL-22R1[2]. |
| No Any Chemical & Physical Properties |